Results 231 to 240 of about 30,561 (295)
DFT-ML-Based Property Prediction of Transition Metal Complex Photosensitizers for Photodynamic Therapy. [PDF]
Gao J, Dong Y, Qiu T, Sun W, Du J.
europepmc +1 more source
Systematic modeling of porphyrin-based photosensitizers for inhibiting Mycobacterium tuberculosis β-Carbonic Anhydrases. [PDF]
Manaithiya A +9 more
europepmc +1 more source
Biomolecule-Photosensitizer Conjugates: A Strategy to Enhance Selectivity and Therapeutic Efficacy in Photodynamic Therapy. [PDF]
Płaskonka DM +4 more
europepmc +1 more source
Decontamination from water pollutants and pathogens by electrospun nanofibers doped with heavy-atom-free borafluorene-BODIPY photosensitizers. [PDF]
Zaszczyńska A +11 more
europepmc +1 more source
Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions
Photodynamic therapy (PDT) is a minimally invasive therapeutic modality that has gained great attention in the past years as a new therapy for cancer treatment.
J H Correia +2 more
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Die Makromolekulare Chemie, Rapid Communications, 1984
Copolymerisation du cinnamate de vinyloxyethyle avec le (nitro-4 phenoxy)-2 ethyl vinyl ether ou le (nitro-4 naphtyl oxy)-2 ethyl vinyl ...
Tadatomi Nishikubo +3 more
openaire +1 more source
Copolymerisation du cinnamate de vinyloxyethyle avec le (nitro-4 phenoxy)-2 ethyl vinyl ether ou le (nitro-4 naphtyl oxy)-2 ethyl vinyl ...
Tadatomi Nishikubo +3 more
openaire +1 more source
The Prognosis of Photosensitivity
Epilepsia, 1986Summary: Since 1968, annual EEG recordings during photic stimulation using a standardised technique have been made on photosensitive patients and siblings. In 1983, 72 were aged ≥20 years and 14 were aged 16–19 years. Mean duration of follow‐up was 9.8 ± 4.8 years.
P M, Jeavons, A, Bishop, G F, Harding
openaire +2 more sources
Lupus, 2000
A wide variety of skin conditions may present in patients with lupus erythematosus (LE). These can be broadly divided into three main groups: cutaneous forms of LE (`LE-specific skin disease'), nonspecific cutaneous manifestations of SLE (`LE non-specific skin disease') and cutaneous complications of drug treatments for LE.
Millard, T P, Hawk, J L M, McGregor, J M
openaire +2 more sources
A wide variety of skin conditions may present in patients with lupus erythematosus (LE). These can be broadly divided into three main groups: cutaneous forms of LE (`LE-specific skin disease'), nonspecific cutaneous manifestations of SLE (`LE non-specific skin disease') and cutaneous complications of drug treatments for LE.
Millard, T P, Hawk, J L M, McGregor, J M
openaire +2 more sources

